Valuation Metrics and Recent Changes
UTI AMC’s current P/E ratio stands at 20.92, a figure that places it in the ‘fair’ valuation category according to recent assessments. This marks a departure from its previous standing as ‘very attractive,’ reflecting a re-rating of the stock’s earnings multiple. The price-to-book value ratio is currently 3.06, which, while not excessive, indicates a premium over book value that investors are willing to pay for the company’s asset management capabilities and growth prospects.
Other valuation multiples include an EV to EBIT of 13.86 and EV to EBITDA of 13.17, both suggesting moderate valuation levels relative to earnings before interest, taxes, depreciation, and amortisation. The EV to capital employed ratio is 3.28, and EV to sales is 7.01, further underscoring a balanced valuation stance. The PEG ratio remains at zero, signalling either a lack of meaningful earnings growth expectations or a data anomaly, which warrants cautious interpretation.
Comparative Analysis with Industry Peers
When compared with its peers in the capital markets sector, UTI AMC’s valuation appears more reasonable. Several competitors, including Poonawalla Finance, Go Digit General Insurance, and Star Health Insurance, are classified as ‘very expensive’ with P/E ratios soaring above 58 and EV/EBITDA multiples reaching triple digits in some cases. For instance, Poonawalla Finance trades at a P/E of 95.52 and an EV/EBITDA of 23.67, while Go Digit General Insurance’s EV/EBITDA is an eye-watering 121.96.
Other notable peers such as Anand Rathi Wealth and Aditya AMC also carry ‘very expensive’ tags with P/E ratios of 67.09 and 22.97 respectively. In contrast, UTI AMC’s P/E of 20.92 and EV/EBITDA of 13.17 position it as a more moderately priced option within the sector, potentially offering value for investors seeking exposure to capital markets without the premium multiples.
Financial Performance and Returns
UTI AMC’s financial health remains robust, with a return on capital employed (ROCE) of 21.95% and return on equity (ROE) of 13.41%, reflecting efficient utilisation of capital and shareholder funds. The dividend yield of 4.58% adds an attractive income component for investors, especially in a low-interest-rate environment.
Stock price movements have been mixed over various time horizons. The company’s current market price is ₹1,045.60, up 4.60% on the day from a previous close of ₹999.65. The 52-week high and low stand at ₹1,494.95 and ₹906.40 respectively, indicating a wide trading range over the past year.
In terms of returns, UTI AMC outperformed the Sensex over the medium to long term. Over three years, the stock delivered a 50.39% return compared to the Sensex’s 37.63%, and over five years, it returned 85.09% versus the Sensex’s 66.63%. However, more recent performance has been less encouraging, with a one-month return of -7.06% against the Sensex’s -2.36%, and a year-to-date return of -7.39% compared to the Sensex’s -1.74%. The one-year return of 2.54% also lags behind the Sensex’s 8.49%, suggesting short-term headwinds.
Transformation in full progress! This Micro Cap from Auto Ancillary just achieved sustainable profitability after tough times. Be early to witness this powerful comeback story!
- - Sustainable profitability reached
- - Post-turnaround strength
- - Comeback story unfolding
Mojo Score and Rating Update
UTI AMC’s MarketsMOJO score currently stands at 41.0, reflecting a cautious outlook. The company’s Mojo Grade was downgraded from ‘Hold’ to ‘Sell’ on 30 October 2025, signalling a less favourable risk-reward profile. The market capitalisation grade remains low at 3, consistent with its small-cap status within the capital markets sector.
This downgrade aligns with the valuation shift from very attractive to fair, indicating that while the stock is no longer undervalued, it is not excessively priced either. Investors should weigh this alongside the company’s solid fundamentals and dividend yield when considering portfolio allocation.
Sector and Market Context
The capital markets sector has seen significant valuation divergence, with many companies trading at elevated multiples driven by growth expectations and sectoral tailwinds. UTI AMC’s more moderate valuation may appeal to value-conscious investors amid rising interest rates and macroeconomic uncertainties that could temper growth prospects for more richly valued peers.
Moreover, UTI AMC’s consistent profitability metrics and dividend yield provide a defensive cushion, making it a potentially attractive option for investors seeking stable income and moderate capital appreciation within the sector.
UTI Asset Management Company Ltd or something better? Our SwitchER feature analyzes this small-cap Capital Markets stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Investment Considerations and Outlook
Investors evaluating UTI AMC should consider the stock’s fair valuation in the context of its historical performance and sector dynamics. The downgrade in valuation attractiveness suggests limited upside from current levels, especially given the stock’s recent underperformance relative to the Sensex over short-term periods.
However, the company’s strong return on capital employed and equity, coupled with a healthy dividend yield, provide a foundation for steady returns. The stock’s moderate P/E and P/BV ratios relative to expensive peers may offer a margin of safety in volatile markets.
Potential risks include sector-specific headwinds, regulatory changes affecting asset management fees, and broader market volatility. Conversely, any improvement in earnings growth or market sentiment could prompt a re-rating and improved investor sentiment.
Conclusion
UTI Asset Management Company Ltd’s shift from very attractive to fair valuation reflects a recalibration of investor expectations amid evolving market conditions. While the stock no longer offers a deep value proposition, its reasonable multiples, solid profitability metrics, and dividend yield make it a viable candidate for investors seeking exposure to the capital markets sector with a balanced risk profile.
Comparisons with peers highlight UTI AMC’s relative affordability, though recent price performance suggests caution in the near term. Investors should monitor earnings updates, sector trends, and valuation shifts closely to determine the optimal entry or exit points.
Unlock special upgrade rates for a limited period. Start Saving Now →
